Financial ServicesFinanceOther Financial Services

Biogen Pharmachem Industries Ltd

Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 27 filings·Updated 5 Aug 2026
Showing 10 of 27 filings.
5 Aug 20262 filings
Company UpdateReg. 32 (1), (3) - Statement of Deviation & Variation

Company declares no unutilised funds from past fundraising; no deviation reported

Utilisation status and deviation

  • Purpose: declaration of non-applicability due to zero unutilised funds.
  • Mode of fund raising: not disclosed.
  • Status: no unutilised funds; proceeds fully utilised.
  • Deviation: none; no variation to report.
Filed 16:06View Source
Board MeetingOutcome of Board Meeting

Biogen Pharmachem approves unaudited standalone quarterly results for quarter ended 30 June 2026

Financial results and audit status

  • Board approved unaudited standalone results for quarter ended 30 June 2026.
  • Audit Committee reviewed; statutory auditors carried out a limited review.
  • Total income for the quarter ended 30 June 2026: 44.34 lacs.
  • Net profit after tax for the quarter: 22.14 lacs.
  • Single segment; no separate segment results.
  • Paid-up equity share capital: 10,530.37 lacs.
  • Statutory auditors conducted limited review; no audit opinion expressed.
Filed 15:43View Source
7 Jul 20261 filing
Company UpdateCertificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate confirms listing of dematerialised securities and cancellation of physical certificates; no demat requests received

Dematerialisation status

  • The securities have been listed on the stock exchanges.
  • Physical certificates were mutilated and cancelled; depository name substituted as registered owner.
  • No physical certificates were received for demat during the quarter.
Filed 15:20View Source
20 May 20263 filings
Insider Trading / SASTDisclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Rama Shiva Lease Finance Pvt Ltd

Filed 10:04View Source
Insider Trading / SASTDisclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Rama Shiva Lease Finance Pvt Ltd

Filed 10:01View Source
Insider Trading / SASTDisclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Parichay Infrastructure Ltd

Filed 09:53View Source
1 Apr 20261 filing
Corp. ActionRecord Date

Biogen Pharmachem Industries Ltd - 531752 - Regulation 42 As Per SEBI LODR Intimation Of Record Date For Issuance Of Bonus Shares In The Proportion Of 1:6 I.E. 1 (One) New Equity Shares Of Rs.1/- Each For Every 6 (Six) Existing Equity Shares Of Rs.1/- Each Fully Paid Up And Held By The Members/ Beneficial Owner

Bonus Issue Record Date

  • Record date fixed as 15 May 2026 for bonus shares entitlement
  • Bonus shares issued at ratio of 1 new share per 6 existing shares
  • Bonus shares are equity shares of Rs.1 each fully paid
  • Issuance subject to shareholder approval via postal ballot and e-voting
Filed 11:41View Source
25 Mar 20261 filing
24 Mar 20261 filing
23 Mar 20261 filing
Showing 10 of 27 filings